| 000 | 01187 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512104811.0 | ||
| 264 | 0 | _c19741210 | |
| 008 | 197412s 0 0 eng d | ||
| 022 | _a0007-1447 | ||
| 024 | 7 |
_a10.1136/bmj.3.5926.313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCunningham, J L | |
| 245 | 0 | 0 |
_aAcetanilide oxidation in phenylbutazone-associated hypoplastic anaemia. _h[electronic resource] |
| 260 |
_bBritish medical journal _cAug 1974 |
||
| 300 |
_a313-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetanilides _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnemia, Aplastic _xchemically induced |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPhenylbutazone _xadverse effects |
| 700 | 1 | _aLeyland, M J | |
| 700 | 1 | _aDelamore, I W | |
| 700 | 1 | _aEvans, D A | |
| 773 | 0 |
_tBritish medical journal _gvol. 3 _gno. 5926 _gp. 313-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.3.5926.313 _zAvailable from publisher's website |
| 999 |
_c4416464 _d4416464 |
||